{"id":5640,"date":"2023-11-15T06:56:32","date_gmt":"2023-11-15T06:56:32","guid":{"rendered":"https:\/\/aceoncology.org\/?post_type=ace_education&#038;p=5640"},"modified":"2023-12-18T12:20:39","modified_gmt":"2023-12-18T12:20:39","slug":"expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc","status":"publish","type":"ace_education","link":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/","title":{"rendered":"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC)"},"content":{"rendered":"\n<p>Muscle-Invasive Bladder Cancer (MIBC) is defined as the tumor has spread through the bladder lining and into the bladder muscle. Optimal treatment strategies for MIBC requires the involvement of a specialist multidisciplinary team (MDT), with collaboration between surgeons, medical oncologists, radiation oncologists, pathologists and other specialists.<\/p>\n\n\n\n<div style=\"height:19px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Bladder preservation is an alternative to cystectomy for patients deemed unfit for surgery. The MDT board should develop a treatment strategy tailored to meet the needs of patients seeking bladder preservation. The management of locally advanced operable bladder cancer and the role of pre and postoperative systemic treatments have become increasingly intricate. Neoadjuvant cisplatin-based chemotherapy has been the standard of care for some years. Adjuvant immunotherapy has now emerged as a new standard of care for postoperative patients with high risks. Nonetheless, there remain gaps that need to be addressed for practicing oncologists to gain an in-depth understanding of individualized treatment strategies for MIBC.<\/p>\n\n\n\n<div style=\"height:14px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Let&#8217;s watch the recorded video on &#8216;Frequently Asked Questions (FAQs) for MIBC&#8217; to gain comprehensive insights from leading experts \u2013 Dr. Francisco X. Real from National Cancer Research Center of Spain, Dr. F\u00e9lix Guerrero Ramos from Hospital Universitario 12 de Octubre in Madrid, Dr. Natalia Carballo and Dr. Enrique Grande from MD Anderson Cancer Center Madrid.<\/p>\n\n\n\n<div style=\"height:19px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>This program is available with subtitles in the following languages:<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/05\/Screenshot-2023-05-10-144115.png\" alt=\"This image has an empty alt attribute; its file name is Screenshot-2023-05-10-144115.png\"\/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Muscle-Invasive Bladder Cancer (MIBC) is defined as the [&hellip;]<\/p>\n","protected":false},"author":719,"featured_media":5288,"template":"","ace_education_category":[35],"ace_education_tag":[],"class_list":["post-5640","ace_education","type-ace_education","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC) - ACE Oncology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC) - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"Muscle-Invasive Bladder Cancer (MIBC) is defined as the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-18T12:20:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"721\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/\",\"name\":\"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC) - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg\",\"datePublished\":\"2023-11-15T06:56:32+00:00\",\"dateModified\":\"2023-12-18T12:20:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg\",\"width\":721,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5728\u7ebf\u6559\u80b2\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/education\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC) - ACE Oncology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/","og_locale":"zh_CN","og_type":"article","og_title":"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC) - ACE Oncology","og_description":"Muscle-Invasive Bladder Cancer (MIBC) is defined as the [&hellip;]","og_url":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/","og_site_name":"ACE Oncology","article_modified_time":"2023-12-18T12:20:39+00:00","og_image":[{"width":721,"height":450,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ace_oncology","twitter_misc":{"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/","url":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/","name":"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC) - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg","datePublished":"2023-11-15T06:56:32+00:00","dateModified":"2023-12-18T12:20:39+00:00","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2023\/04\/ExpertReviewUC_webthumbnail_721x450.jpg","width":721,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/education\/expert-interview-2-frequently-asked-questions-faqs-for-muscle-invasive-bladder-cancer-mibc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5728\u7ebf\u6559\u80b2","item":"https:\/\/aceoncology.org\/zh-hans\/education\/"},{"@type":"ListItem","position":3,"name":"Expert Interview 2: Frequently Asked Questions (FAQs) for Muscle-Invasive Bladder Cancer (MIBC)"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education\/5640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/ace_education"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/719"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/5288"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=5640"}],"wp:term":[{"taxonomy":"ace_education_category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education_category?post=5640"},{"taxonomy":"ace_education_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/ace_education_tag?post=5640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}